Y Intercept Hong Kong Ltd Takes $2.76 Million Position in Oscar Health, Inc. (NYSE:OSCR)

Y Intercept Hong Kong Ltd purchased a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 130,338 shares of the company's stock, valued at approximately $2,764,000. Y Intercept Hong Kong Ltd owned 0.05% of Oscar Health at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the business. Point72 Hong Kong Ltd bought a new position in shares of Oscar Health in the second quarter valued at approximately $78,000. Quest Partners LLC acquired a new position in Oscar Health in the second quarter worth $93,000. KBC Group NV grew its holdings in shares of Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company's stock worth $97,000 after purchasing an additional 1,328 shares during the last quarter. Amalgamated Bank increased its stake in shares of Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company's stock valued at $106,000 after buying an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors bought a new position in shares of Oscar Health in the third quarter valued at about $142,000. Institutional investors and hedge funds own 75.70% of the company's stock.

Oscar Health Stock Down 9.2 %

NYSE:OSCR traded down $1.53 during trading hours on Tuesday, reaching $15.02. 4,940,244 shares of the stock were exchanged, compared to its average volume of 3,452,520. The stock has a market cap of $3.71 billion, a PE ratio of -259.17 and a beta of 1.64. Oscar Health, Inc. has a twelve month low of $7.50 and a twelve month high of $23.79. The firm has a 50 day moving average of $16.80 and a 200 day moving average of $17.77. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). The business had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm's revenue for the quarter was up 68.3% on a year-over-year basis. During the same period last year, the business posted ($0.29) EPS. On average, equities analysts expect that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Insider Activity at Oscar Health

In related news, Vice Chairman Joshua Kushner purchased 276,040 shares of the business's stock in a transaction that occurred on Monday, November 11th. The stock was acquired at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the completion of the purchase, the insider now owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. This represents a 5.80 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thrive Partners Vii Growth Gp, acquired 420,819 shares of the stock in a transaction on Tuesday, November 12th. The shares were bought at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the purchase, the director now owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. This trade represents a 8.36 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have weighed in on OSCR shares. Jefferies Financial Group started coverage on shares of Oscar Health in a research note on Tuesday. They issued an "underperform" rating and a $12.00 target price for the company. UBS Group assumed coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a "neutral" rating and a $23.00 price objective for the company. Piper Sandler reiterated an "overweight" rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, Bank of America downgraded Oscar Health from a "neutral" rating to an "underperform" rating and dropped their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Oscar Health has an average rating of "Hold" and an average price target of $21.56.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.